Key Points
- Director William Federici bought 20,000 Stevanato Group shares for €274,400, increasing his holdings by 74.1% to 46,991 shares.
- Stevanato reported quarterly EPS of €0.16, below the €0.17 analyst consensus, on revenue of €326.06 million.
- Analysts lowered price targets, including Citigroup to $20 and UBS to $16; overall, the stock carries a Moderate Buy consensus rating.
Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) Director William Federici bought 20,000 shares of the company's stock in a transaction dated Monday, November 9th. The stock was bought at an average price of €13.72 per share, for a total transaction of €274,400.00. Following the transaction, the director owned 46,991 shares of the company's stock, valued at approximately €644,716.52. This trade represents a 74.10% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Stevanato Group Stock Down 0.2%
STVN stock opened at €14.33 on Friday. The stock has a market capitalization of $4.34 billion, a P/E ratio of 24.70, a P/E/G ratio of 1.44 and a beta of 0.80. The firm has a 50-day simple moving average of €19.23 and a 200-day simple moving average of €17.92. The company has a quick ratio of 1.19, a current ratio of 1.73 and a debt-to-equity ratio of 0.22. Stevanato Group S.p.A. has a 52 week low of €12.05 and a 52 week high of €24.01.
Stevanato Group (NYSE:STVN - Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported €0.16 earnings per share for the quarter, missing analysts' consensus estimates of €0.17 by (€0.01). Stevanato Group had a net margin of 11.24% and a return on equity of 10.51%. The company had revenue of €326.06 million during the quarter. Equities analysts forecast that Stevanato Group S.p.A. will post 0.67 earnings per share for the current fiscal year.
Institutional Trading of Stevanato Group
Institutional investors have recently added to or reduced their stakes in the stock. Wellington Management Group LLP acquired a new position in Stevanato Group during the second quarter worth $22,621,000. Ranger Investment Management L.P. acquired a new stake in shares of Stevanato Group during the second quarter worth about $21,438,000. Cooper Investors PTY Ltd. boosted its stake in shares of Stevanato Group by 4.4% in the second quarter. Cooper Investors PTY Ltd. now owns 668,494 shares of the company's stock valued at $12,080,000 after purchasing an additional 28,265 shares during the period. Schwartz Investment Counsel Inc. grew its holdings in shares of Stevanato Group by 15.0% in the third quarter. Schwartz Investment Counsel Inc. now owns 661,136 shares of the company's stock valued at $13,871,000 after purchasing an additional 86,385 shares in the last quarter. Finally, Riverbridge Partners LLC boosted its position in Stevanato Group by 4.2% in the 3rd quarter. Riverbridge Partners LLC now owns 625,914 shares of the company's stock valued at $13,132,000 after buying an additional 25,400 shares during the period.
Analysts Set New Price Targets
A number of research firms have recently issued reports on STVN. Citigroup dropped their target price on shares of Stevanato Group from $26.00 to $20.00 and set a "buy" rating for the company in a report on Wednesday, November 4th. UBS Group reduced their target price on shares of Stevanato Group from $23.00 to $16.00 and set a "neutral" rating on the stock in a research note on Wednesday, November 4th. Weiss Ratings upgraded shares of Stevanato Group from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, August 27th. William Blair cut shares of Stevanato Group from an "outperform" rating to a "market perform" rating in a research note on Wednesday, November 4th. Finally, Deutsche Bank started coverage on shares of Stevanato Group in a report on Wednesday, October 7th. They set a "hold" rating for the company. Two investment analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat, Stevanato Group currently has a consensus rating of "Moderate Buy".
Get Our Latest Stock Analysis on Stevanato Group
Stevanato Group Company Profile
(
Get Free Report)
Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
